Eric Latimer, PhD, is a health economist and looks for ways to improve the services to people with severe forms of mental illness.

Ridha Joober developed a pharmaco-genetic profile of schizophrenia that may lead to earlier diagnosis and more effective treatment.

Jacques Tremblay is actively involved in quality assurance, and in improving the safety of medication use.

N.P. Vasavan Nair, M.D., FRCPC, has contributed to the Douglas Institute in a variety of capacities.

Hani Iskandar has been involved in clinical research projects in the fields of schizophrenia, mood disorders and pharmacology.  

Christina Gianoulakis wants to elucidate the role of the endogenous opioid peptide systems in mediating the reinforcing effects of alcohol.

Serge Gauthier has contributed to the development of new diagnostic and therapeutic approaches to Alzheimer's Disease and other dementing disorders.  

Marie-Josée Fleury studies healthcare system organizations and evaluation of mental health services.

Jean-Bruno Debruille studies the processes that precede and permit the conscious perception using fMRI and ERPs.

Jean Caron's research relates mainly to the epidemiology of mental illnesses and suicide.